HomeCSTL • NASDAQ
Castle Biosciences Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 87.99M | 20.57% |
Operating expense | 99.53M | 54.19% |
Net income | -25.85M | -920.05% |
Net profit margin | -29.38 | -746.69% |
Earnings per share | -0.90 | -900.00% |
EBITDA | 1.84M | 186.16% |
Effective tax rate | 1.61% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 275.15M | 15.02% |
Total assets | 501.72M | 9.42% |
Total liabilities | 61.41M | 9.57% |
Total equity | 440.31M | — |
Shares outstanding | 28.87M | — |
Price to book | 1.07 | — |
Return on assets | -13.52% | — |
Return on capital | -14.72% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -25.85M | -920.05% |
Cash from operations | -6.04M | 11.69% |
Cash from investing | -22.43M | -13.86% |
Cash from financing | -1.55M | -114.59% |
Net change in cash | -30.02M | -88.90% |
Free cash flow | -1.10M | 93.27% |
Previous close
$16.32
Day range
$15.84 - $16.79
Year range
$15.71 - $35.84
Market cap
473.36M USD
Avg Volume
498.51K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2007
Headquarters
Website
Employees
784
